ReviewCurrent hematologic malignancy reports2025

Navigating the Economic Burden of Multiple Myeloma: Insights into Cost-effectiveness of CAR-T and Bispecific Antibody Therapies.

Praneeth Reddy Keesari et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.